ArticleImmunity, inflammation and disease2024

Clinical benefits of novel non-nucleoside reverse transcriptase inhibitors: A prospective cohort study.

Shujing Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.